BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 34557973)

  • 21. [Coumarin or DOAC in frail elderly patients with atrial fibrillation?].
    Joosten LPT; van Doorn S; Hemels MEW; Huisman MV; Rutten FH; Geersing GJ
    Ned Tijdschr Geneeskd; 2024 Jan; 168():. PubMed ID: 38525862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
    Ha FJ; Barra S; Brown AJ; Begley DA; Grace AA; Agarwal S
    Int J Cardiol; 2018 Jul; 262():51-56. PubMed ID: 29606512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics.
    Chen CM; Chang KH; Wang CL; Tu HT; Huang YT; Wu HC; Chang CH; Chang SH
    Front Pharmacol; 2022; 13():819878. PubMed ID: 35496319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Antithrombotic Therapy Versus Anticoagulant Monotherapy for Major Adverse Limb Events in Patients with Concomitant Lower Extremity Arterial Disease and Atrial Fibrillation: A Propensity Score Weighted Analysis.
    Lin DS; Wu HP; Chung WJ; Hsueh SK; Hsu PC; Lee JK; Chen CC; Huang HL
    Eur J Vasc Endovasc Surg; 2024 May; ():. PubMed ID: 38754724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation.
    Kido K; Shimizu M; Shiga T; Hashiguchi M
    J Am Pharm Assoc (2003); 2022; 62(2):487-495.e2. PubMed ID: 34815185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants.
    Lee JY; Oh IY; Lee JH; Kim SY; Kwon SS; Yang HJ; Kim YK; Bang SM
    Thromb Res; 2020 Nov; 195():243-249. PubMed ID: 32823239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.
    Yamaji H; Higashiya S; Murakami T; Hina K; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):246-254. PubMed ID: 31498193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation.
    Hellfritzsch M; Wang SV; Grove EL; Gagne JJ; Hallas J; Pottegård A
    Am J Epidemiol; 2020 Dec; 189(12):1467-1477. PubMed ID: 32639512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding Risk of Warfarin and Direct Oral Anticoagulants in Younger Population: A Historical Cohort Study Using a Japanese Claims Database.
    Yokoyama S; Tanaka Y; Nakagita K; Hosomi K; Takada M
    Int J Med Sci; 2018; 15(14):1686-1693. PubMed ID: 30588192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients.
    Shurrab M; Jackevicius CA; Austin PC; Tu K; Qiu F; Caswell J; Michael F; Andrade JG; Ko DT
    J Interv Card Electrophysiol; 2023 Apr; 66(3):629-635. PubMed ID: 36149579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapy.
    Tran E; Ledbetter LE
    J Thromb Thrombolysis; 2023 May; 55(4):721-728. PubMed ID: 36781620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer.
    Yasui T; Shioyama W; Oboshi M; Oka T; Fujita M
    Intern Med; 2019 Jul; 58(13):1845-1849. PubMed ID: 30799369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation.
    Harskamp RE; Teichert M; Lucassen WAM; van Weert HCPM; Lopes RD
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):615-623. PubMed ID: 31520256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world direct oral anticoagulant experience in atrial fibrillation: falls risk and low dose anticoagulation are predictive of both bleeding and stroke risk.
    Brook R; Aswapanyawongse O; Tacey M; Kitipornchai T; Ho P; Lim HY
    Intern Med J; 2020 Nov; 50(11):1359-1366. PubMed ID: 31566857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
    Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of bleeding in patients receiving direct oral anticoagulants.
    Chua GS; Pham J; Anpalahan M
    Intern Med J; 2022 Apr; 52(4):581-589. PubMed ID: 33197139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.